<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Lv J</submitter><pubmed_abstract>Polysaccharides, vital biological macromolecules ubiquitous in organisms, have garnered attention as potential therapeutic candidates for ulcerative colitis (UC). However, the therapeutic potential of &lt;i>Rhodiola crenulata&lt;/i> polysaccharides (RCP) in UC remains largely unexplored. The RCP was prepared by boiling water extraction, 80% alcohol precipitation, membrane separation, and D101 macroporous resin purification. The monosaccharide composition of RCP (Mw = 67.848 kDa) includes mannose, rhamnose, glucuronic acid, galacturonic acid, glucose, galactose, and arabinose, with a molar ratio of 0.22:1:0.07:7.03:2.88:0.64:4.12. &lt;i>In vivo&lt;/i> experiments have shown that RCP can improve DSS induced weight loss in UC mice, decrease disease activity index (DAI), alleviate histopathological change</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>1519038</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11979201</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>&amp;lt;i&amp;gt;Rhodiola crenulata&amp;lt;/i&amp;gt; polysaccharide alleviates dextran sulfate sodium-induced ulcerative colitis in mice by repairing the intestinal barrier and regulating the intestinal microecology.</pubmed_title><pmcid>PMC11979201</pmcid><pubmed_authors>Lv J</pubmed_authors><pubmed_authors>Cao L</pubmed_authors><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Luo F</pubmed_authors><pubmed_authors>Xiao W</pubmed_authors><pubmed_authors>Su Z</pubmed_authors><pubmed_authors>Suo F</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Kong X</pubmed_authors><pubmed_authors>Li M</pubmed_authors><pubmed_authors>Liu W</pubmed_authors></additional><is_claimable>false</is_claimable><name>&amp;lt;i&amp;gt;Rhodiola crenulata&amp;lt;/i&amp;gt; polysaccharide alleviates dextran sulfate sodium-induced ulcerative colitis in mice by repairing the intestinal barrier and regulating the intestinal microecology.</name><description>Polysaccharides, vital biological macromolecules ubiquitous in organisms, have garnered attention as potential therapeutic candidates for ulcerative colitis (UC). However, the therapeutic potential of &lt;i>Rhodiola crenulata&lt;/i> polysaccharides (RCP) in UC remains largely unexplored. The RCP was prepared by boiling water extraction, 80% alcohol precipitation, membrane separation, and D101 macroporous resin purification. The monosaccharide composition of RCP (Mw = 67.848 kDa) includes mannose, rhamnose, glucuronic acid, galacturonic acid, glucose, galactose, and arabinose, with a molar ratio of 0.22:1:0.07:7.03:2.88:0.64:4.12. &lt;i>In vivo&lt;/i> experiments have shown that RCP can improve DSS induced weight loss in UC mice, decrease disease activity index (DAI), alleviate histopathological change</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2025-07-05T03:04:30.19Z</modification><creation>2025-07-05T03:04:30.19Z</creation></dates><accession>S-EPMC11979201</accession><cross_references><pubmed>40206066</pubmed><doi>10.3389/fphar.2025.1519038</doi></cross_references></HashMap>